ATTENUATION OF 5-HT1A AND 5-HT2 BUT NOT 5-HT1C RECEPTOR MEDIATED BEHAVIOR IN RATS FOLLOWING CHRONIC TREATMENT WITH 5-HT RECEPTOR AGONISTS, ANTAGONISTS OR ANTI-DEPRESSANTS

被引:46
作者
BERENDSEN, HHG
BROEKKAMP, CLE
机构
[1] Department of CNS Pharmacology, Organon International B.V., Oss, NL-5340 BH
关键词
CHRONIC TREATMENT; 5-HT RECEPTOR SUBTYPES; LOWER LIP RETRACTION; PENILE ERECTIONS; HEAD SHAKES; ANTIDEPRESSANTS; RAT;
D O I
10.1007/BF02244313
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The effects of chronic (10 days) treatment with serotonin (5-HT) receptor agonists on 5-HT1A receptor mediated lower lip retraction (LLR), 5-HT1C receptor mediated penile erections (PE) or 5-HT2 receptor mediated head shakes (HS) were studied in rats. It was found that the 5-HT1A and 5-HT2 receptor mediated behaviour could be attenuated after chronic treatment, whereas 5-HT1C receptor mediated behaviour remained unchanged. The ED50 for the 5-HT1A receptor mediated, 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT)-induced LLR showed an increase from 0.07 mg/kg in placebo pretreated rats to 0.13 in 8-OH-DPAT (1 mg/kg/day) pretreated rats. The number of 5-HT2 receptor mediated (+/-)-1-2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI) (0.46 and 1 mg/kg)-induced HS was significantly reduced (67% and 50%, respectively) after 10 days' pretreatment with DOI (1 mg/kg/day). In the same animals the number of 5-HT1C receptor mediated PE was increased. Ten days' pretreatment with MK 212 (0.46 mg/kg/day) failed to affect MK 212 (0.22 and 0.46 mg/kg/)-induced PE. In addition, the effects of chronic treatment with some antidepressants were studied. The monoamine oxidase (MAO) inhibitor tranylcypromine (4 mg/kg/day) given for 10 days caused an increase in the ED50 for 8-OH-DPAT induced LLR (ED50 values were 0.06 and 0.14 mg/kg, respectively, in placebo - and tranylcypromine - pretreated rats) and attenuated MK 212 (0.22 and 0.46 mg/kg)-induced PE. Chronic treatment with mianserin (10 mg/kg/day), a tetracyclic antidepressant with 5-HT1C and 5-HT2 receptor antagonistic properties, did not change PE induced by MK 212, but caused an increase of PE induced by DOI and a decrease of DOI-induced HS. Ten days' pretreatment with the 5-HT re-uptake inhibitor Org 6997 (5 mg/kg/day) had no effect on MK 212-induced PE. The results demonstrate that 5-HT1A and 5-HT2 but not 5-HT1C receptor mediated behaviour can be attenuated by chronic treatment with agonists for these receptors. The 5-HT1C receptor mediated behaviour remains unchanged in response to chronic agonist treatment. Chronic treatment with anti-depressants have differential effect on these behaviours. The possible implication for the mechanism of action of antidepressants is discussed.
引用
收藏
页码:219 / 224
页数:6
相关论文
共 50 条
[1]   AN EXAMINATION OF THE BEHAVIORAL SPECIFICITY OF HYPOPHAGIA INDUCED BY 5-HT1B, 5-HT1C AND 5-HT2 RECEPTOR AGONISTS USING THE POSTPRANDIAL SATIETY SEQUENCE IN RATS [J].
KITCHENER, SJ ;
DOURISH, CT .
PSYCHOPHARMACOLOGY, 1994, 113 (3-4) :369-377
[2]   The effects of 5-HT1A receptor agonists, 5-HT1A receptor antagonists and their interaction on the fear-potentiated startle response [J].
Joordens, RJE ;
Hijzen, TH ;
Olivier, B .
PSYCHOPHARMACOLOGY, 1998, 139 (04) :383-390
[3]   The effects of 5-HT1A receptor agonists, 5-HT1A receptor antagonists and their interaction on the fear-potentiated startle response [J].
R. J. E. Joordens ;
T. H. Hijzen ;
B. Olivier .
Psychopharmacology, 1998, 139 :383-390
[4]   SPINAL SUPERSENSITIVITY TO 5-HT1, 5-HT2 AND 5-HT3 RECEPTOR AGONISTS FOLLOWING 5,7-DIHYDROXYTRYPTAMINE [J].
SAWYNOK, J ;
REID, A .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1994, 264 (03) :249-257
[5]   Effect of a selective 5-HT reuptake inhibitor in combination with 5-HT1A and 5-HT1B receptor antagonists on extracellular 5-HT in rat frontal cortex in vivo [J].
Sharp, T ;
Umbers, V ;
Gartside, SE .
BRITISH JOURNAL OF PHARMACOLOGY, 1997, 121 (05) :941-946
[6]   NOVEL REGULATION OF 5-HT1C RECEPTORS - DOWN-REGULATION INDUCED BOTH BY 5-HT1C/2 RECEPTOR AGONISTS AND ANTAGONISTS [J].
PRANZATELLI, MR ;
MURTHY, JN ;
TAILOR, PT .
EUROPEAN JOURNAL OF PHARMACOLOGY-MOLECULAR PHARMACOLOGY SECTION, 1993, 244 (01) :1-5
[7]   5-HT(1A)-MEDIATED LOWER LIP RETRACTION - EFFECTS OF 5-HT(1A) AGONISTS AND ANTAGONISTS [J].
MOORE, NA ;
REES, G ;
SANGER, G ;
PERRETT, L .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1993, 46 (01) :141-143
[8]   EFFECTS OF REPEATED TREATMENT WITH FLUOXETINE AND CITALOPRAM, 5-HT UPTAKE INHIBITORS, ON 5-HT1A AND 5-HT2 RECEPTORS IN THE RAT-BRAIN [J].
KLIMEK, V ;
ZAKKNAPIK, J ;
MACKOWIAK, M .
JOURNAL OF PSYCHIATRY & NEUROSCIENCE, 1994, 19 (01) :63-67
[9]   INVOLVEMENT OF THE 5-HT2 RECEPTOR IN THE 5-HT RECEPTOR-MEDIATED STIMULATION OF PROLACTIN-RELEASE [J].
ALBINSSON, A ;
PALAZIDOU, E ;
STEPHENSON, J ;
ANDERSSON, G .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1994, 251 (2-3) :157-161
[10]   Role of 5-HT1B, 5-HT2A and 5-HT2C receptors in the generalization of 5-HT receptor agonists to the ethanol cue in the rat [J].
Maurel, S ;
Schreiber, R ;
De Vry, J .
BEHAVIOURAL PHARMACOLOGY, 1998, 9 (04) :337-343